Eleven Amaryllidaceae alkaloids (1-11) were isolated from fresh bulbs of Chlidanthus fragrans Herb. The chemical structures were elucidated by MS, and 1D and 2D NMR spectroscopic experiments. Complete NMR assignments were achieved for deoxypretazzetine (1). All compounds were evaluated for their erythrocytic acetylcholinesterase and serum butyrylcholinesterase inhibition activity using Ellman´s method. In the prolyl oligopeptidase assay, Z-Gly-Pro-pnitroanilide was used as substrate. In biological assays, only the crinine type Amaryllidaceae alkaloid undulatine showed promising acetylcholinesterase and prolyl oligopeptidase inhibition activity with IC 50 values of 23.0 ± 1.0 µM and 1.96 ± 0.12 mM, respectively. Other isolated compounds were considered inactive.
Plants of the Amaryllidaceae are known to produce structurally unique alkaloids with a wide range of interesting physiological effects, including antitumor, antiviral, acetylcholinesterase inhibitory and immunostimulatory activities [1a-1d] . These alkaloids are restricted to this family and are best known due to galanthamine, a selective and reversible inhibitor of acetylcholinesterase that increases the levels of acetylcholine (ACh) in the brain, and used, therefore, in the treatment of Alzheimer´s disease (AD).
AD is the most predominant cause of dementia in the elderly, affecting more than 20 million people worldwide and it is estimated that this figure will increase to 114 million by 2040 [2a] . AD is the fourth leading cause of death for people over 65 years in Western industrial countries and is becoming more and more common. In other words, increased life expectancy is directly related to the increasing number of elderly people and consequently proportional to the rising number of senile disorders, including neurodegenerative diseases. The etiology of AD is still unknown, but postmortem studies have shown two characteristic pathologic hallmarks, senile plaques (SPs) and neurofibrillary tangles (NFTs). SPs are an extracellular accumulation of beta-amyloid (Aß) surrounded by dystrophic neurites and microglia. Aß originates from the proteolysis of the amyloid precursor protein (APP) through sequential cleavage by beta-site amyloid precursor protein-cleaving enzyme 1 (BACE-1, ß-secretase) and γ-secretase [2b]. In AD patients, deficit of the neurotransmitter acetylcholine in the cortex results in deterioration of the level of cholinergic functions, and this is responsible for the memory impairments [2c]. The principal role of acetylcholinesterase (AChE) is the termination of nerve impulse transmission at the cholinergic synapses by rapid hydrolysis of ACh. However, not only AChE participates in the cholinergic regulation of the central nervous system (CNS) in humans, but also another enzyme, butyrylcholinesterase (BuChE), which is able to hydrolyze ACh, as well as other esters [2d]. BuChE is associated with the NFTs and SPs and its activity increases in the AD brain, where it co-localizes with Aß fibrils [2e]. In severe AD, levels of AChE and choline acetyltransferase are decreased by as much as 90% compared with normal stage, while the concentration of BuChE increases [2f]. This fact has targeted BuChE as a new approach to affect the progression of AD. Therefore, research into new inhibitors with dual enzymatic activity is required. Currently, acetylcholinesterase inhibition is the most used therapeutic treatment for the symptoms of AD [2g].
Prolyl oligopeptidase (POP) is a cytosolic serine peptidase that hydrolyzes small proline-containing peptides at the carboxy terminus of proline-residues such as vasopressine, substance P, and thyrotropin-releasing hormones that are involved in the process of learning and memory [3a-3b] . These neuropeptides are known to be important modulators in cognitive functions, and degradation of these peptides by POP may accelerate the aging process and possibly be involved in age-related neurodegenerative diseases [3c]. In recent years, POP has gained importance as a target for the treatment of schizophrenia (SZ), bipolar affective disorder (BD) and cognitive disturbances, such as those present in AD, mainly due to its involvement in the metabolism of inositol-1,4,5-P 3 (IP 3 ), which is a key molecule in the transduction cascade of neuropeptide signaling. Some inhibitors of POP have been found to be potent antidementia drugs [3d-3e], and, therefore, the inhibition of POP could be an important supporting tool in the treatment of AD.
The genus Chlidanthus includes ten species of tender bulbs from tropical South America, mostly native to the Andes. The botanical NPC Natural Product Communications 2013 Vol. 8 No. 11 1541 -1544 name of Chlidanthus fragrans comes from the Greek, meaning 'delicate flower' [4a] . Previous phytochemical study resulted in the isolation of four main alkaloids, galanthamine, chlidanthine, lycorine and tazettine [4b-4c]. Our previous GC/MS investigation of the alkaloid extract of this species led to the identification of fifteen alkaloids belonging to five structural-types of Amaryllidaceae alkaloids, and this extract showed interesting acetylcholinsterase inhibition activity, with an IC 50 value of 20.1 ± 2.9 μM [4d].
The important bioactivities of the Amaryllidaceae alkaloids, together with the absence of a current phytochemical study of Ch. fragrans, encouraged us to examine this species. Here we report the isolation and identification of eleven Amaryllidaceae alkaloids from the bulbs of Ch. fragrans. Extensive chromatographic purification afforded the previously known alkaloids deoxypretazettine (1), belladine (2), 3-epimacronine (3), ismine (4), undulatine (5), buphanisine (6), tazzetine (7) , galanthamine (8), chlidanthine (9), ambelline (10) and lycorine (11) . The isolated alkaloids belong to the galanthamine (8 and 9), tazettine (1, 3 and 7), crinine (5, 6 and 10), lycorine (11), belladine (2) and narciclasine (4) structure types. The structures were determined by comparison of their MS and NMR spectra, and physical properties with literature values. Alkaloids 1-6 and 10 are reported for the first time for the genus Chlidanthus. Lycorine (11), tazzetine (7), ambelline (10), galanthamine (8), undulatine (5), belladine (2) and ismine (4) are common Amaryllidaceae alkaloids, which are synthesized by a wide range of Amaryllidaceae species [4b, 5, 6] . Opposite to these compounds, chlidanthine and deoxypretazettine are rare. The structure of deoxypretazettine (1) was established in 1980, but only limited 1 H NMR spectroscopic data are available [7] . Here we report the complete NMR assignments for deoxypretazzetine (1; Figure 1 ), achieved through the use of two-dimensional NMR techniques (COSY, gHSQC, gHMBC and ROESY). Chlidanthine (9) is the second major compound of the studied plant species and its chemotaxonomic marker. In previous phytochemical studies of Zephyranthes concolor, Haemanthus multiflorus and Hippeastrum aulicum, chlidanthine (9) was isolated only in small amounts [8a-8c]. The isolated compounds were assayed for their inhibitory activity against erythrocytic acetylcholinesterase (HuAChE), serum butyrylcholineserase (HuBuChE) and prolyl oligopeptidase (POP) (see Table 1 ). Galanthamine hydrobromide, huperzine A and eserine were used as the positive controls in the HuAChE and HuBuChE assays, and Z-Pro-prolinal and baicaline in the POP assay. The strongest HuAChE and HuBuChE inhibition activity was demonstrated by galanthamine (8), the hydrobromide of which is approved for the treatment of AD as a long acting, selective, reversible and competitive AChE inhibitor [2c, 9] . It is reported that, among plants of the Amaryllidaceae, the AChE (electric eel) inhibition activity in vitro is associated mainly with galanthamine and lycorine type skeleta (with the exception of lycorine itself), but not with the haemanthamine, homolycorine and tazettine classes [9, 10] . Lycorine type compounds are less active inhibitors than the galanthamine type and their activity is associated with substitution at positions C-1 and C-2 [9] . Regarding the galanthamine type alkaloids, until now three more potent than galanthamine (8) have been found. The loss of the methyl group at C-9, as in sanguinine, leads to about a 10-fold increase of the AChE inhibitory activity [9] . The activity is completely lost in molecules of the galanthamine type with hydrogenated C4-C4a double bonds (lycoramine and epinorlycoramine). The existence of an intramolecular hydrogen bond between the hydroxyl on C-3 and the oxygen of the dihydrofuran ring of galanthamine (8) has been considered to play a major role in its acetylcholinesterase inhibitory activity [11] . In the case of chlidanthine (9) , which is a positional isomer of galanthamine, the ability to inhibit acetylcholinesterase is strongly reduced (IC 50 = 147 ± 6 μM). Crinine type alkaloids are reported to possess only weak inhibition activity. The haemanthamine and crinine type alkaloids differ only in the position of the 5,10b-ethano bridge, but it appears that the stereochemistry of this bridge has no effect on the inhibition of AChE activity [10] . Contrary to these conclusions, the HuAChE inhibition activity of undulatine (5, IC 50 = 23 ± 1 µM) is interesting and, together with the results of the POP assay, where only undulatine (5) possessed inhibition activity (IC 50 = 1.96 ± 0.12 mM), which was comparable with that of the standard baicaline (IC 50 = 0.610 ± 0.021 mM), could make this an important structure in the search and development of new active compounds for the treatment of AD. Of the other crinine type alkaloids, 8-Odemethylmaritide, which we previously isolated from Zephyranthes robusta [12] , also showed important HuAChE inhibition activity with an IC 50 value of 28.0 ± 0.9 µM. In the current study, 3epimacronine (3), ismine (4) and buphanisine (6) also showed some HuAChE inhibition activity. According to their IC 50 values, they are only weak inhibitors in comparison with the used standards. The other alkaloids were considered inactive. Unfortunately, the obtained amounts of compounds 1, 3 and 6 were insufficient to determine an IC 50 in the POP assay.
As mentioned above, BuChE plays an important role in the late AD stages, but only a limited number of Amaryllidaceae alkaloids have been tested so far for their BuChE inhibition activity. Therefore, it is impossible to draw conclusions on the influence of particular functionalities on the BuChE inhibition activity of Amaryllidaceae alkaloids as yet. In this study, only galanthamine (8) and the narciclassine type alkaloid ismine (4) showed moderate HuBuChE inhibition activity. A wider range of these compounds must be isolated and tested first.
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In conclusion, Ch. fragrans is an important source of Amaryllidaceae alkaloids with biological activities. Complete NMR assignments were achieved for deoxypretazettine (1), through the use of two-dimensional NMR techniques. Important HuAChE inhibition activity was shown by the crinine type alkaloid undulatine. This alkaloid also possessed POP inhibition activity comparable with that of the used standard, baicaline. Some alkaloids were isolated in amounts that will allow preparation of new derivatives for biological assays. AChE and BuChE continue to be attractive targets for rational drug design and discovery of mechanism-based inhibitors for the treatment of AD. POP has been suggested to play an important role in the biological regulation of peptide hormones and is recognized to be involved in learning and memory.
Experimental

Plant materials:
The fresh bulbs of Ch. fragrans Herb. were obtained from the herbal dealer Lukon Glads (Sadská, Czech Republic). Botanical identification was performed by Prof. L. Opletal, CSc. A voucher specimen is deposited in the herbarium of the Faculty of Pharmacy in Hradec Králové.
Materials:
Acetylthiocholine iodide (ATChI), butyrylthiocholine iodide (BuTChI), eserine, prolyl oligopeptidase (POP) and its substrate, Z-Gly-Pro-p-nitroanilide, were purchased from Sigma-Aldrich, Czech Republic, galanthamine hydrobromide from Changsha Organic Herb Inc., China, and huperzine A from Tai´an zhonghui Plant Biochemical Co., Ltd., China. The red blood cell ghosts used as a source of acetylcholinesterase (HuAChE), and human plasma as a source of butyrylcholinesterase (HuBuChE) were prepared in our laboratory.
General experimental procedures: NMR spectra were recorded for CDCl 3 and THF-d 8 solutions at ambient temperature on a VNMR S500 NMR spectrometer operating at 500 MHz for 1 H and 125 MHz for 13 C. Chemical shifts were recorded as δ values in parts per million (ppm), and were indirectly referenced to tetramethylsilane (TMS) via the solvent signal (7.26 ppm for 1 H and 77.0 ppm for 13 C for CDCl 3 , and 3.30 ppm for 1 H and 49.0 ppm for 13 C for CD 3 OD). Coupling constants (J) are given in Hz. For unambiguous assignment of 1 H and 13 C signals 2D NMR spectra (COSY, gHSQC, gHMBC and ROESY) were measured using standard parameter sets and pulse programs delivered by the producer of the spectrometer. The EI-MS were obtained on an Agilent 7890A GC 
Extraction and isolation of alkaloids:
Fresh bulbs (6 kg) were crushed and exhaustively extracted with EtOH (96% v/v, 2 x) at room temperature for 48 h and the combined macerate was filtered and evaporated to dryness under reduced pressure. The bulb crude extract (350 g) was acidified to pH 2 with 2% HCl, defatted with diethyl ether (4 x 300 mL), and alkalized to pH 9-10 with 25% ammonia. Then, the alkaloids were extracted with CHCl 3 (4 x 300 mL). The extract was evaporated under vacuum and tested for alkaloids on TLC (silica gel 60; To: Et 2 NH 95:5, 2 x). The extract (6.5 g), which was Dragendorff positive, was further fractionated by CC (aluminum oxide), eluting with light petrol gradually enriched with CHCl 3, and then CHCl 3 enriched with EtOH. Fractions of 150 mL were collected and monitored by TLC; 6 main fractions containing alkaloids were obtained (I-VI). Fraction I (260 mg) was subjected to preparative TLC (To: Et 2 NH, 95:5) to give 2 subfractions Ia (50 mg) and Ib (120 mg). Both subfraction were again subjected to preparative TLC (cHx: Et 2 NH, 9:1, 3 x) and from Ia were isolated compounds 1 (2.6 mg) and 2 (15 mg), and from subfraction Ib compounds 3 (5 mg) and 4 (18 mg). From fraction II (180 mg) compound 5 (55 mg) was obtained by crystallization from EtOH. The mother liquor was subjected to preparative TLC (To: cHx: Et2NH, 65:30:5) and compounds 3 (2 mg) and 6 (3 mg) were isolated. Compound 7 (2.9 g) crystallized spontaneously from fraction III (3.25 g). The mother liquors of fractions III and IV were combined and subjected to preparative TLC (To: Et 2 NH, 9:1, 2 x) and compound 8 (75 mg) was obtained and recrystallized from acetone. From fraction V (1.3 g), compound 9 (850 mg) was obtained by crystallization from CHCl 3 : EtOH, 1:1. Fraction VI (320 mg) was subjected to preparative TLC (To: CHCl 3 : Et 2 NH, 5:5:1) and compounds 10 (25 mg) and 11 (90 mg) were obtained. The other alkaloids were identified by comparison with published data: belladine (2) [5] ; 3-epimacronine (3) [6] ; ismine (4) [13] ; undulatine (5) [14] ; buphanisine (6) [15] ; tazzetine (7) [16] ; galanthamine (8) [17] ; chlidanthine (9) [8a] ; ambelline (10) [14] ; lycorine (11) [18] . Copies of the original spectra are obtainable from the author for correspondence.
Acetylcholinesterase and butyrylcholinesterase assay, preparation of red blood cell ghosts:
The same procedures were used as in our previous report [12] .
